To shareholders and investors
Top Message
We would like to express our gratitude to shareholders and investors for continued support.
During the fiscal year ended March 2024 under review, the Japanese economy showed signs of a gradual recovery amid the normalization of economic activity associated with the reclassification of COVID-19 as Class 5 and improving employment and income conditions. However, the outlook remains uncertain due to concerns of the risk of a downturn in overseas economies, rising prices, the continued depreciation of the yen and other factors.
In this environment, the Group continued to supply a diverse range of fluoride products in line with the needs of customers, as well as developing the chemical product distribution business based on the unique know-how acquired in the transportation of special cargo.
In regard to the performance for the fiscal year ended March 2024 under review, in the Semiconductors, shipment volume declined due to deterioration in the semiconductor market, and shipment volume also fell in the Industrial Hydrofluoric Acid and the General Products. As a result, sales revenue decreased to 30,446 millions of yen (down 14.0% year on year).
In terms of profits, having been buffeted by a decline in sales revenue, operating profit amounted to 2,722 millions of yen (down 22.5% year on year), ordinary profit amounted to 3,064 millions of yen (down 29.5% yearon year), profit attributable to owners of parent amounted to 1,845 millions of yen (down 19.1% year on year),mainly as a result of impairment losses that were recorded as extraordinary losses in relation to productionfacilities for additives for lithium-ion secondary batteries in the High-purity Chemical Business.
For the consolidated results forecast for the next fiscal year ended March 2025, Sales in the Semiconductors, which is a mainstay of the business, are expected to increase as a result of the effects of the gradual recovery of the semiconductor market, and an increase in sales of enriched boron (boron-10) used in nuclear energy-related facilities is expected in the Energy under the High-purity Chemical Business. Accordingly, the Group forecasts sales revenue of 34,500 millions of yen (up 13.3% year on year), operating profit of 3,650 millions of yen (up 34.1% year on year), ordinary profit of 3,550 millions of yen (up 15.8% year on year), and profit attributable to owners of parent of 42,600 millions of yen (up 40.9% year on year).
We appreciate your further understanding and support in the future.
May 2024